Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Peer-reviewed

Research Article

Cell Entry and Trafficking of Human Adenovirus Bound to Blood Factor X Is Determined by the Fiber Serotype and Not Hexon:Heparan Sulfate Interaction

Abstract

Human adenovirus serotype 5 (HAdV5)-based vectors administered intravenously accumulate in the liver as the result of their direct binding to blood coagulation factor X (FX) and subsequent interaction of the FX-HAdV5 complex with heparan sulfate proteoglycan (HSPG) at the surface of liver cells. Intriguingly, the serotype 35 fiber-pseudotyped vector HAdV5F35 has liver transduction efficiencies 4-logs lower than HAdV5, even though both vectors carry the same hexon capsomeres. In order to reconcile this apparent paradox, we investigated the possible role of other viral capsid proteins on the FX/HSPG-mediated cellular uptake of HAdV5-based vectors. Using CAR- and CD46-negative CHO cells varying in HSPG expression, we confirmed that FX bound to serotype 5 hexon protein and to HAdV5 and HAdV5F35 virions via its Gla-domain, and enhanced the binding of both vectors to surface-immobilized hypersulfated heparin and cellular HSPG. Using penton mutants, we found that the positive effect of FX on HAdV5 binding to HSPG and cell transduction did not depend on the penton base RGD and fiber shaft KKTK motifs. However, we found that FX had no enhancing effect on the HAdV5F35-mediated cell transduction, but a negative effect which did not involve the cell attachment or endocytic step, but the intracellular trafficking and nuclear import of the FX-HAdV5F35 complex. By cellular imaging, HAdV5F35 particles were observed to accumulate in the late endosomal compartment, and were released in significant amounts into the extracellular medium via exocytosis. We showed that the stability of serotype 5 hexon∶FX interaction was higher at low pH compared to neutral pH, which could account for the retention of FX-HAdV5F35 complexes in the late endosomes. Our results suggested that, despite the high affinity interaction of hexon capsomeres to FX and cell surface HSPG, the adenoviral fiber acted as the dominant determinant of the internalization and trafficking pathway of HAdV5-based vectors.

Citation: Corjon S, Gonzalez G, Henning P, Grichine A, Lindholm L, Boulanger P, et al. (2011) Cell Entry and Trafficking of Human Adenovirus Bound to Blood Factor X Is Determined by the Fiber Serotype and Not Hexon:Heparan Sulfate Interaction. PLoS ONE 6(5): e18205. https://doi.org/10.1371/journal.pone.0018205

Editor: Robert J. Geraghty, University of Minnesota, United States of America

Received: November 17, 2010; Accepted: February 28, 2011; Published: May 26, 2011

Copyright: © 2011 Corjon et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: The work in France (Lyon and Grenoble) was supported by the French Cystic Fibrosis Foundation (Vaincre la Mucoviscidose, VLM contracts TG0801 and TG0901), the French Agency for AIDS Research (ANRS, DendrAde contract 2007–2008), the University of Lyon-1 and the Centre National de la Recherche Scientifique (FRE-3011), and the Région Rhône-Alpes (Cluster 10-Infectiology). SC was the recipient of an ANRS fellowship, and GG of a VLM fellowship. SSH is the recipient of a Contrat d'Interface HCL-INSERM (2008–2012). The funders in France had no role in our study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work in Sweden for the construction of the chimeric adenoviral vector was supported by Got-a-Gene AB, and potential financial competing interests exist.

Competing interests: LL is affiliated with Got-a-Gene AB, but this affiliation does not alter the authors' adherence to all the PLoS ONE policies on sharing data.

Introduction

The human adenovirus (HAdV) capsid is composed of eleven well identified structural proteins, of which the hexon is the major component with 240 copies forming the 20 facets and 30 edges of the icosahedral capsid. The penton is the second most represented capsid protein, with 12 copies of penton located at each apex. Each penton capsomere is made up of a fiber, a triple beta-stranded fibrous protein [1], anchored to a pentameric protein, the penton base, closing up the vertices of the icosahedron (reviewed in [2], [3]). HAdVs are divided into subgroups or species A to F, covering 51 different serotypes. The members of species C (HAdV2, HAdV5) and species B (HAdV3, HAdV35) are the most studied and characterized in terms of capsid structure, cell entry mechanisms, cellular response and gene transfer (reviewed in [2], [3]). The classical cell entry and trafficking pathway of HAdV5, as demonstrated by epithelial cell models of adenoviral infection in vitro, consists of (i) the fiber binding to CAR, the Coxsackie B and Adenovirus Receptor [4]–[11], followed by (ii) the interaction of the penton base RGD motifs with the cellular integrins alphaVbeta3 and alphaVbeta5, [12]–[15], which promotes virus endocytosis into clathrin-coated vesicles [16], [17]. In step (iii), partially uncoated HAdV5 particles are released from the early endosomal compartment into the cytosol, a process involving the capsid protein VI [18], [19]. (iv) Dynein and microtubules mediate the cytoplasmic transit of the residual HAdV5 capsid, which docks at the nuclear pore complex [20], [21], before (v) the nuclear import of the viral nucleoprotein core [22], [23].

Contrasting with the vast scientific information available on HAdV5 and its multiple interactions with host cell components, the clinical application of HAdV5, the most widely utilised serotype as gene transfer vector, has suffered from several drawbacks. The prevalence of anti-HAdV antibodies in the human population results in the rapid neutralisation of HAdV5 vector after in vivo administration. Secondly, intravenous delivery of HAdV5 vector results in the liver uptake of the vast majority of the virus particles, and therefore do not reach their target cells or tissues. Numerous strategies have been employed to overcome these hurdles, notably by engineering mutant or chimeric vectors to evade the neutralising antibodies and ablate the hepatotropism of the vector, but the results have been somewhat disappointing (reviewed in [24]).

Recent breakthrough in the HAdV-host interactions showed that the vector particle accumulation in the liver is the result of HAdV5 binding to human blood coagulation factor X (FX) via the hexon capsomeres, followed by the interaction of the HAdV5-FX complexes to heparan sulfate proteoglycan (HSPG) molecules which are present in high concentration at the surface of Kupffer cells [25]–[34]. Further dissection of the molecular mechanism of the HPSG-mediated cellular uptake of HAdV5-FX complex revealed the importance of O- and N-sulfation of HPSG in this high affinity pathway, and the requirement of alphaV integrins as secondary receptors for an efficient internalization step [35]. In contrast to HAdV5, it has been observed in vivo that HAdV35 vectors have liver transduction efficiencies which are of four orders of magnitude lower than that of HAdV5 vectors [36]. Likewise, fiber-pseudotyped or chimeric fiber-carrying HAdV5 vectors showed less hepatotropism, compared to HAdV5. This was the case for HAdV5F35, which carried serotype 35 fibers [37], HAdV5/35 chimeric vector, which carried serotype 35 fiber knob domains [38], and HAdV5F2/BAdV4, carrying chimeric human-bovine fibers [39]. Intriguingly however, HAdV5, HAdV5F35 and HAdV5F2/BAdV4 vectors were all composed of the serotype 5 hexon capsomere, thus suggesting the contribution of factors other than hexon, FX and HSPG to the mechanism of liver uptake of FX-HAdV5 complex in vivo. Both HAdV35 and the HAdV5F35 chimera use CD46, one of the cell attachment receptors recognized by subspecies B HAdVs besides desmoglein-2 [40], and to a lesser degree HSPG molecules, to infect epithelial cells [41]–[44].

In the present study, we sought to determine the influence of capsid proteins other than the hexon, viz. penton base and/or fiber, on the interaction of FX with HAdV5-based vectors, and their FX- and HSPG-mediated cell entry pathway and gene transduction. To this aim, we analyzed the binding of wild type HAdV5 (HAdV5wt), penton base or fiber mutants of HAdV5, and fiber 35-pseudotyped HAdV5 vector (HAdV5F35) to heparan sulfate in the presence or absence of FX by surface plasmon resonance in vitro. We analyzed the effect of FX on the HAdV5wt- and HAdV5F35-mediated transduction of CHO cells expressing HSPG (CHO-K1), the alternative receptors for HAdV5 [45]–[47] and HAdV35 viruses [41]–[44], and HSPG-negative CHO cells (CHO-2241). Both cell lines lack the CD46 and CAR receptors for HAdV5F35 and HAdV5, respectively.

We found that FX bound to HAdV5 hexon protein via its Gla-domain, and enhanced the binding of HAdV5wt and HAdV5F35 vector particles to surface-immobilized hypersulfated heparin (HS) in vitro, and to cellular HSPG in vivo. We also found that FX augmented the efficiency of cellular transduction by HAdV5, but had a negative effect on the transduction by HAdV5F35. Our experimental data showed that this negative effect did not involve the cell attachment or the endocytic step of the FX-HAdV5F35 complex, but the intracellular trafficking. In the presence of FX, the HAdV5F35 particles accumulated in the late endosomal compartment, resulting in a delay in their vesicular release and nuclear import. Furthermore, HAdV5F35 were released in significant amounts in the extracellular medium via exocytosis, resulting in lower numbers of particles reaching the nucleus. Our results suggested that the serotype 35 fiber determined the cell internalization and trafficking pathway of the HAdV5F35 vector, despite the absence of known fiber receptor at the plasma membrane, and acted dominantly despite the interaction between hexon and cell surface HSPG mediated by FX. This observation has significant implications for the future design of target tissue-redirected adenoviral vectors.

Results

Gla domain-dependence of FX-mediated binding of serotype 5 hexon protein and adenovirions to heparan sulfate in vitro

The interaction between soluble HAdV5wt hexon protein and heparan sulfate in vitro, directly or indirectly via FX, was investigated using surface plasmon resonance (SPR) analysis and a hypersulfated form of heparin (HS), recognized as the best structural model to mimic the heparan sulfate chains contained in HSPG [48], [49]. HS was covalently immobilized onto the biosensor chip, and the binding of hexon to HS was assessed using FX in a stoichiometric ratio of 1∶1 with hexon protein. A truncated version of FX devoid of its gamma-carboxylic acid (Gla) domain, FXGL, was assayed in parallel experiments. As expected from previous studies (reviewed in [24]), we found that hexon binding to HS was enhanced in the presence of FX, but not with FXGL (Fig. 1 A), and this enhancing effect occurred in a FX dose-dependent manner (not shown). The binding of HAdV5wt virions to immobilized HS with and without FX was also assessed by SPR, using various stoichiometric ratios of FX per hexon trimeric capsomere, as determined from the number of virus particles present in the samples. FX enhanced the binding of HAdV5wt virions to HS in a dose-dependent manner (Fig. 1 B). As for isolated hexon protein, the Gla domainless FXGL showed no significant enhancement of the binding of HAdV5wt virion to HS (not shown). Of note, a weak signal of binding was observed with control samples of FX alone (Fig. 1 A), used in amounts equivalent to its average physiological concentration in human adult serum (8 µg/ml), referred to as the maximum FX concentration (FXmax). This excluded the possibility that the signal of binding to HS observed with FX∶hexon or FX∶vector complexes were due to the binding of free FX.

thumbnail
Download:
Figure 1. SPR analysis of the in vitro binding of HAdV5 hexon capsomeres and HAdV5-based vectors to immobilized HS with or without factor X (FX) bridging.

Representative sensorgrams for (A) HAdV5 hexon capsomeres alone, or with FX or Gla domainless FXGL, (B) HAdV5wt virions alone or with FX, and (C) HAdV5 virion mutants HAdV5FTTAT and HAdV5PbEGD alone or with FX. In (A) and (B), the molecular ratio of FX to hexon protein (isolated capsomeres as in (A), or virion-encapsidated hexons, as in (B)) is indicated in parenthesis. The control sensorgrams with FX and FXGL alone were obtained at FX and FXGL concentrations of 8 µg/ml, corresponding to the concentration in human adult serum (FXmax). In (C), FX was also used at 8 mg/ml. Hexon capsomeres, HAdV5wt virions and HAdV5FTTAT and HAdV5PbEGD mutants bound to immobilized HS only in the presence of FX. RU, response units.

https://doi.org/10.1371/journal.pone.0018205.g001

Two mutants of HAdV5 were then analyzed, HAdV5FTTAT, mutated in the KKTK motif of the fiber shaft, and HAdV5PbEGD, mutated in the RGD motif of the penton base. The KKTK tetrapeptide had been identified as a putative HSPG-binding motif [45], [46], [50], a function which is debatable [51]. FX used at 8 µg/ml (FXmax) was found to enhance the binding of the two mutants to HS to equivalent levels (Fig. 1 C). As for HAdV5wt, no binding enhancement was observed with the Gla domainless version FXGL, indicating that the FX bridge between HAdV5wt hexon and HS required the integrity of its Gla domain. This confirmed previous reports which showed that the Gla domain of FX interacts with the hexon capsomere [26], [33], whilst basic residues Arg240, Lys236, Lys169, Arg165, Lys96, Arg93, and Arg125 in the exosite of FX interact with HSPG [52]. Our results also indicated that the mutations in HAdV5FTTAT and HAdV5PbEGD had no effect on the FX-mediated binding function of HAdV5wt hexon to HS.

Requirement of HSPG expression at the cell surface for FX-mediated enhancement of cell transduction by HAdV5wt vector

We next assayed the transduction efficiency of HAdV5wt vector in the presence or absence of FX or FXGL in a CAR-negative cellular model, using CHO cells, which express HSPG at their surface (control CHO-K1), or CHO-2241, which are deficient in HSPG expression. The FX concentrations in the viral inoculum ranged from 0 to 8 µg/ml (FXmax). In HSPG-positive CHO-K1 cells, FX, but not the Gla domainless FXGL, enhanced the transduction efficiency (TE) of HAdV5wt in a dose-dependent manner (Fig. 2 A). Of note, the maximum enhancement of transduction was not reached with a concentration of FX in the medium corresponding to a ratio of 720 copies of FX per virion (i.e. with 3 FX per trimeric hexon capsomere), but with the highest FX concentration (FXmax; Fig. 2 A), a result consistent with sensorgrams shown in Fig. 1B. At FXmax, the increase of TE was 18-fold at 2,500 vp/cell, and 26-fold at 5,000 vp/cell (Fig. 2 B). No detectable effect of FX on TE levels was observed in HSPG-negative CHO-2241 cells (Fig. 2 B). This demonstrated that the surface expression of HSPG molecules was indispensable for the FX-mediated enhancing effect on the HAdV5wt cell binding and transduction, confirming previous studies [24], [37].

thumbnail
Download:
Figure 2. Cell transduction of CAR- and CD46-negative CHO cells by HAdV5wt in the absence of presence of FX.

(A), Dose-response effect of FX on cell transduction. CHO-K1 cells were transduced by GFP-expressing HAdV5wt vector in the presence of increasing concentration of FX. Both FXmax and FXGLmax corresponded to 8 mg/ml. Results were expressed as relative transduction efficiency (RTE). Transduction efficiency, in arbitrary units (AU), was given using the formula∶TE = (percentage of GFP-positive cells)×(MFI). The RTE was calculated using the formula∶RTE = (TE with FX)∶(TE without FX), with the 1-value attributed to TE in the absence of FX. (B), CHO-K1 (double CAR- and CD46-negative cells) and CHO-2241 (triple CAR- , CD46-, and HSPG-negative cells) were transduced by HAdV5wt vector at MOI 2,500 (left half of the bar graph) or MOI 5,000 (right half of the bar graph) in the absence or presence of FX (8 µg/ml). Results were expressed as RTE, with the 1-value attributed to the TE of CHO-K1 in the absence of FX.

https://doi.org/10.1371/journal.pone.0018205.g002

Absence of requirement of fiber KKTK motif and penton base RGD motif for FX- and HSPG-mediated enhancement of cell transduction by HAdV5 vectors

It was shown that mutation of the putative HSPG binding site in the HAdV5wt shaft (91KKTK94) interfered negatively with the cellular trafficking of the virions to the nucleus [45], [51]. We therefore evaluated the influence of FX on the capacity of transducing CHO-K1 and CHO-2241 cells by the mutant vector HAdV5FTTAT. In the absence of FX, HAdV5FTTAT transduced CHO-K1 cells with a significantly lower TE, compared to HAdV5wt used at the same MOI (2,500 vp/cell ; Fig. 3 A). In the presence of increasing doses of FX, we observed a progressive augmentation of the TE, with a 35-fold enhancement for the FX∶virion ratio of 3∶1 for (viz. 720 copies of FX per 240 hexon capsomeres), and 65-fold for FXmax (Fig. 3 B). No enhancement, but instead a slight decreasing effect of FX on TE was observed in CHO-2241 (Fig. 3 A). This indicated that FX was able to rescue the loss of infectivity due to the KKTK-to-TTAT mutation in the fiber shaft, provided that HSPG molecules were present at the cell surface. This also indicated that the putative HSPG-binding motif KKTK was dispensable for the FX-mediated bridging of HAdV5wt virion to surface HSPG molecules, confirming the major role of hexon as the ligand of FX [24]. It could not be excluded however that other fiber interactions, besides the assumed interaction with HSPG, might be affected as a consequence of the TTAT mutation, although the TTAT mutant fibers folded as trimers and were incorporated at wild-type levels in the adenoviral capsid (data not shown).

thumbnail
Download:
Figure 3. Transduction of CHO-K1 or CHO-2241 cells by GFP-expressing, fiber mutants of HAdV5-based vectors in the absence (w/o) or presence of (with) FX (8 µg/ml).

(A), HAdV5wt, mutants HAdV5FTTAT and HAdV5PbEGD and serotype 35 fiber-pseudotyped HAdV5F35 were all used at MOI 2,500, and transduction efficiency were expressed as arbitrary units (AU), as described in the legend to Fig. 2. (B), Dose-response effect of FX on cell transduction by HAdV5FTTAT mutant. CHO-K1 cells were transduced by GFP-expressing HAdV5FTTAT mutant vector in the presence of increasing concentration of FX (FXmax = 8 µg/ml). Results were expressed as relative transduction efficiency (RTE; refer to the legend to Fig. 2).

https://doi.org/10.1371/journal.pone.0018205.g003

Human adenovirus serotype 35 (HAdV35) utilizes CD46 and αv-integrins as primary and secondary receptors, respectively [41], [53]. We next investigated the possible influence of RGD-dependent integrins on the FX+HSPG-mediated enhancing effect on transduction by HAdV5 vectors. To this aim, the HAdV5PbEGD penton base mutant was used in transduction assays of CHO-K1 and CHO-2241 cells. In the absence of FX, HAdV5PbEGD showed a lower TE of both CHO-K1 and CHO-2241 cells, compared to HAdV5wt used at the same MOI (Fig. 3 A). In the presence of FXmax, we observed an enhancement of transduction of CHO-K1 cells, at levels similar to those of HAdV5wt or HAdV5FTTAT (50- to 100-fold), whereas no effect was detectable in CHO-2241 (Fig. 3 A). This showed that FX was able to rescue the negative effect of the penton base RGD-to-EGD mutation in HSPG-expressing CHO-KI cells, but not in HSPG-negative CHO cells. Similar to the HAdV5FTTAT fiber shaft mutant, this result implied that the penton base RGD motifs and the integrins played no significant role in the FX+HSPG-mediated enhancement of cell transduction using HAdV5 vectors.

Interestingly, CHO-2241 seemed to be slightly more permissive to HAdV5wt compared to CHO-K1 infected at the same MOI in the absence of FX, which could suggest a higher accessiblity of alternative virus attachment receptor(s) other than HSPG for the primary binding of HAdV5wt to CHO-2241 cells, e.g. integrins [12], [54], [55]. The possibility of integrins acting as alternative attachment receptor of Ad5 to CHO cells in the absence of CAR and HSPG were envisaged, based on the results obtained with our RGD-mutant vector : HAdV5PbEGD transduced CHO-2241 cells in the absence of FXmax with a 10-fold lower efficiency, compared to HAdV5wt (Fig. 3 A). However, since CHO cells lack ß-integrins and fail to express αVß3/5 integrin heterodimers at their surface, other types of RGD-interactors/ligands might be responsible for the low levels of HAdV5PbEGD-mediated transduction.

Paradoxical behavior of serotype 35 fiber-pseudotyped HAdV5F35 vector in the context of FX and HSPG

Fiber swapping between adenovirus serotypes has been widely used as a rational strategy to (i) explore the various functions associated with fibers in fundamental virology [56]–[58], (ii) to allow fiber-pseudotyped vectors to evade prexisting neutralizing antibodies [59], [60], or (iii) to ablate the natural tropism of the virus and confer a novel transductional retargeting capacity to the pseudotyped vectors [24], [27], [34], [37], [61]–[67]. Novel and sometimes unexpected properties, e.g. nonnative entry pathway and/or aberrant cellular trafficking, have been observed with such chimeric adenoviruses. This was the case for the serotype 35 fiber-pseudotyped HAdV5F35 vector [68], or for HAdV5F2/BAdV4, which carried bovine-human chimeric fibers [39].

A phylogenetic study of HAdV fiber shaft has revealed the absence of the putative heparan sulfate (HS)-binding site (KKTK motif) in all HAdVs other than species C [69]. The serotype 35 fibers carried by the chimeric HAdV5F35 vector lacked the KKTK motif, and species B HAdV35 has been shown to interact with cellular HSPG via capsid protein domains other than the fiber knob [42]. We therefore wanted to determine the capacity of our chimeric HAdV5F35 vector to bind to HS with or without a FX bridge. Firstly, we analyzed the binding of HAdV5F35 to immobilized FX in SPR assays, and found that HAdV5F35 bound to FX with a higher response compared to HAdV5wt used at the same particle input (Fig. 4 A). We also observed a higher FX-mediated binding of HAdV5F35 to surface-immobilized HS, compared to HAdV5wt (Fig. 4 B). No effect was observed with FXGL (Fig. 4 B). In dose-dependent binding assays, maximum binding was observed with 480 copies of FX per HAdV5F35 virion, i.e. a stoichiometric ratio of 2 FX molecules per hexon capsomere, with no further significant increase obtained using 3 copies of FX per hexon (720 FX copies per virion; Fig. 4 C). This differed from the sensorgrams of FX-mediated binding of HAdV5wt to immobilized HS, which was not maximal with 2 copies of FX per hexon, and still increased in the range 2 to 10 copies of FX per hexon (refer to Fig. 1 C). This difference could be due to the relatively higher accessibility of hexon capsomeres to FX in short fiber-carrying HAdV5F35 vector, compared to the long fiber-carrying vector HAdV5Fwt.

thumbnail
Download:
Figure 4. SPR analysis of the in vitro binding of chimeric HAdV5F35 vector to (A) surface-immobilized FX, or (B, C) immobilized HS with or without FX or FXGL.

(A), Representative sensorgrams for HAdV5wt vector (discontinuous lines) injected at 2×109 and 4×109 vp/ml, or for HAdV5F35 injected at the same doses (solid lines). (B), Comparison of binding to HS of HAdV5wt and HAdV5F35 vector particles (2×109 vp/ml) in the presence of FX or FXGL at 720 copies per vector particle. Controls shown are FX and FXGL alone. For better clarity, the sensorgrams for virions alone, which superimposed those of FX and FXGL, are not shown (refer to Fig. 1C). (C), Dose-response effect of FX on HAdV5F35 binding to immobilized HS. Note that a detectable signal was observed for 120 copies of FX per virion, and reached the maximal value for 480 copies/vp.

https://doi.org/10.1371/journal.pone.0018205.g004

The influence of FX-mediated bridging of HAdV5F35 to cellular HSPG on the transduction of CHO-K1 cell was then tested with increasing MOI, from 200 to 5,000 vp/cell. HAdV5wt was used at the same MOI for comparison and as control. As expected, the transduction efficiency with HAdV5wt vector was significantly higher when FX was added to the virus inoculum, from 14-fold to 30-fold higher at MOI 200 and 5,000 vp/cell, respectively (Fig. 5, A and B, panels a). With HAdV5F35 however, no enhancing effect on transduction of CHO-K1 cells was observed in the presence of FX, compared to the vector alone, but instead a 3- to 4-fold decreasing effect at high MOI (Fig. 5, A and B, panels b). Likewise, in control experiments using HAdV5F35 and permissive CHO-CD46 cells, no increasing effect of FX on cell transduction was observed, but a decreasing effect at high vector doses (Fig. 5, A and B, panels c). A similar phenomenon has previously been reported, and attributed to a blockage in postinternalization step(s) of chimeric vectors carrying serotype 35 fibers [37]. The fact that FX-HAdV5F35 complexes were less efficient than FX-HAdV5wt complexes in cell transduction was paradoxical, considering (i) that both HAdV5wt and HAdV5F35 carried the same hexon capsomeres of serotype 5, (ii) which had the same ligand, FX, and (iii) that the FX-HAdV5F35 complexes were capable of binding to surface-immobilized HS and to cellular HSPG with an apparent higher affinity than that of the FX-HAdV5wt complexes.

thumbnail
Download:
Figure 5. Comparison of transduction efficiency of (a, b) CHO-K1 cells or (c) CHO-CD46 by (a) HAdV5wt, and (b, c) chimeric HAdV5F35 vectors at different MOI (200, 1,000 or 5,000 vp/cell) in the absence (w/o) or presence of (with) FX (8 µg/ml).

Results were expressed as (A) the percentage of GFP-positive cells, or (B) relative transduction efficiency (RTE; refer to the legend to Fig. 2). In B, the number on top of each bar corresponded to the fold increase in RTE, with the 1-value attributed to the TE of CHO-K1 or CHO-CD46 cells transduced by HAdV5F35 at MOI 200. Note that RTE of CHO-K1 cells with HAdV5F35 was lower in the presence of FX than in the absence of FX, at all MOI tested.

https://doi.org/10.1371/journal.pone.0018205.g005

Cell attachment and internalization of FX-HAdV5F35 complex in HSPG-expressing CHO cells

The following experiments were designed to explain the 2-log difference between FX-HAdV5wt and FX-HAdV5F35 complexes in the transduction of CHO-K1 cells. We investigated the (i) cell attachment, (ii) cellular uptake (endocytosis and internalization), and (iii) intracellular trafficking of FX-HAdV5F35, in comparison with FX-HAdV5wt complexes, to determine which step(s) was blocked or altered in the infection pathway. The rationale for using CHO-K1 cells as target cells, was that they express neither CAR nor CD46, and thus made possible the analysis of the cell entry pathway of the HAdV5wt and HAdV5F35 vectors mediated by their FX-bridging to cellular HSPG, while avoiding any bias due to adenovirus serotype-specific receptors.

(i) Cell attachment.

Samples of HAdV5wt and HAdV5F35 suspension were mixed with FX at a final concentration of 8 µg/ml, and the mixture added to CHO-K1 cell monolayers at a MOI of 5,000 vp/cell. Incubation was carried out for 1 h at 4°C, which allowed for virus-cell attachment but not virus entry or endocytosis [70]. After extensive rinsing to remove unattached virus, cells were harvested and cell-bound virus determined by quantitative PCR analysis (qPCR) of viral genomes after DNA extraction, based on the fiber gene copy number normalized to the ß-actin gene. FX significantly increased the amounts of cell-bound virions, by a factor of 5 to 6 for HAdV5wt, and by a factor of 10 for HAdV5F35 (Fig. 6 A). This confirmed the apparent higher affinity of FX for HAdV5F35 as observed in vitro, compared to HAdV5wt (refer to Fig. 4). However, this was in apparent contradiction with the lower transduction efficiency of the FX-HAdV5F35 complex, compared to FX-HAdV5wt (refer to Fig. 5), and excluded the cell attachment as the limiting step for FX-HAdV5F35-mediated transduction.

thumbnail
Download:
Figure 6. Cellular uptake and extracellular release of HAdV5wt and HAdV5F35 vectors by CHO-K1 cells.

(A), Cell attachment of vector (MOI 5,000) was performed at 4°C for 1 h, and cellular internalization at 37°C for 1 h, respectively, with or without FX (8 µg/ml), as indicated on the x-axis. The number of viral genome copies was determined by qPCR of the fiber gene, normalized to the ß-actin gene. (B), Extracellular vectors associated with microvesicles (MVs) or exosomes (EXOs) recovered from the extracellular medium at 72 h post transduction, were determined as above.

https://doi.org/10.1371/journal.pone.0018205.g006

(ii) Cellular uptake.

The subsequent step of endocytosis was then investigated. After an incubation period of 1 h at 4°C with FX-vector complexes at MOI 5,000, as above, samples of CHO-K1 cells were transferred to 37°C and harvested after 1 h. After a brief trypsin treatment, to remove vector particles remaining bound to the plasma membrane [71], cell samples were subjected to DNA extraction and viral genomes determined by qPCR, as above. In the absence of FX, the intracellular content was not significantly different between HAdV5wt and HAdV5F35. In the presence of FX, there was a 2-fold increase in HAdV5wt uptake, and a 4-fold increase for HAdV5F35 (Fig. 6 A). This suggested that the mechanism responsible for the lower cell transduction by the FX-HAdV5F35 complex did not involve the endocytic step of the vector.

(iii) Extracellular release.

The previous results incited us to explore the exocytic pathway of cell-internalized vector particles, i.e. the possibility that significant amounts of HAdV5F35 particles might be released in the extracellular medium, either by shedding of vector-containing microvesicles (MVs) budding from the plasma membrane, or by exocytosis, i.e. the release of exosomes (EXOs) segregated within the lumen of multivesicular bodies (MVBs) (reviewed in [72]). CHO-K1 cell culture supernatants were harvested at 2 h and 24 h post incubation with of HAdV5wt or HAdV5F35 at MOI 5,000, with or without FX. The extracellular MVs and EXOs from the culture supernatants were separated by sequential and differential ultracentrifugation. After DNA extraction, the amount of virus particles in each microparticle population was determined by qPCR quantification of the viral genomes. In the absence of FX, HAdV5wt genomes were recovered in significant amounts in MVs and EXOs, and these amounts decreased in both types of microparticles when transduction was performed in the presence of FX (Fig. 6 B). Interestingly, the profile was different for HAdV5F35, with and without FX: (i) HAdV5F35 genomes were undetectable in either microparticle population in the absence of FX, but became detectable in the presence of FX; (ii) HAdV5F35 was recovered in higher amounts in EXOs, compared to MVs (2-fold; Fig. 6 B). This pattern suggested that the intracellular trafficking was likely responsible for the low efficiency of FX-HSPG-mediated transduction of CHO-K1 cells by HAdV5F35, and the next experiments were designed to determine which subcellular compartment(s) were possibly implicated.

Intracellular trafficking and compartmentalization of FX-HAdV5F35 complexes in HSPG-expressing CHO cells

(i) Live cell imaging.

The capsids of HAdV5wt and HAdV5F35 vectors were chemically labeled with Alexa-488, and mixed with FX, before incubation with CHO-K1 cells at high vector multiplicity (10,000 vp/cell). Intracellular virions were tracked in situ in live cells by time-lapse microscopy at early times of infection (0 to 4 h pi). As early as 20–30 min pi, most of the HAdV5wt signal was found in the vicinity of or within the nucleus (Fig. 7 A). This observation was consistent with the well-described rapid process of endocytosis, endosomal escape and intracellular trafficking of HAdV5wt virions [22], [73], and suggested that FX had no significant effect on the internalized HAdV5wt particles and the kinetics of their intracellular transit. This implied that FX acted at earlier steps, an hypothesis consistent with the role of molecular bridge between viral hexon capsomeres and cell surface HSPG played by FX. The fluorescence pattern of HAdV5F35 vector was however significantly different. At 30 min pi, no fluorescent signal was observed in the nucleus, instead multiple fluorescent dots were visible in the cytoplasm, and most of the fluorescence remained cytoplasmic until 3 h pi (Fig. 7 B). This suggested that HAdV5F35 particles were delayed in terms of intracellular trafficking, compared to HAdV5.

thumbnail
Download:
Figure 7. Confocal microscopy of live cells transduced by adenoviral vector particles or capsid components (penton dodecamers).

(A–C), Confocal microscopy of live cells (CHO-K1) transduced by Alexa-488-labeled adenoviral vectors, used at 10,000 vp/cell and complexed with FX (8 µg/ml). (A) HAdV5wt, 30 min pi; (B, C) HAdV5F35, 3 h pi. (i), Green channel image; (ii), phase contrast; (iii), merge of (i) and (ii). In (C), CHO-K1 cells were transduced by recombinant baculoviral vector expressing RFP-tagged, late endosome marker Lamp1 protein, 24 h before incubation with HAdV5F35 vector. (i), Green channel image; (ii), phase contrast; (iii) orange channel; (iv), merge of (i) and (iii). (D) Live HeLa cells transduced by recombinant baculovirus expressing RFP-tagged, early endosome marker Rab5A protein, were incubated 24 h later with Alexa-488-labeled HAdV5wt particles without FX, at 10,000 vp/cell and 37°C. Picture shown was taken at 20 min after incubation with HAdV5wt. Note that most of the virus signal is weak and diffuse, but some green fluorescent dots are visible within the cytoplasm (white arrows). (E), Live CHO-CD46 cells transduced by recombinant baculovirus expressing RFP-tagged, late endosome marker Lamp1 protein, were incubated 24 h later with Cy5-labeled HAdV3 penton dodecahedrons (Pt-Dd) at 37°C. Picture shown was taken at 60 min after incubation with Pt-Dd. (i), Cy5 channel; (ii), phase contrast image; (iii) RFP channel; (iv), merge of (i) and (iii).

https://doi.org/10.1371/journal.pone.0018205.g007

(ii) Retention of HAdV5F35 particles in the late endosomal compartment.

To determine the nature of the subcellular compartment in which HAdV5F35 was retained, CHO-K1 cells were transduced by baculovirus vectors expressing fluorescent markers designed for live-imaging of different cellular organelles or compartments. We found that the green fluorescent signal of HAdV5F35 colocalized with red fluorescent Lamp1 protein [74], [75], a marker of the lysosomal/late endosomal compartment (Fig. 7 C). This result suggested that the retarded trafficking to the nucleus of HAdV5F35 particles was due to their segregation into the late endosomal compartment.

(iii) Evaluation of the baculovirus-mediated labeling of cellular organelles and compartments for the study of adenoviral vector pathway in living cells.

To verify the validity of our observation of late endosomal compartmentalization of HAdV5F35 particles, HeLa, HEK-293, CHO-K1 or CHO-CD46 cells were transduced with recombinant baculoviruses expressing Lamp1-RFP, as above, or Rab5A-RFP [76], a marker of the early endosomes, 24 h prior to incubation with Alexa-488-labeled HAdV5wt particles or Cy5-labeled HAdV3 penton dodecahedrons (Pt-Dd). No image of colocalisation of Alexa-488 labeled HAdV5wt with RFP-labeled early endosomes could be captured, even after short incubation period: as early as after 10–15 min incubation with living cells at 37°C, green fluorescent dots of HAdV5wt were already found within the cytoplasm, outside of the red fluorescent endosomal compartment (Fig. 7 D). This confirmed the scenario described by Greber et al., which showed that incoming HAdV5wt particles escaped very rapidly from early endosomes [73]. By contrast, Cy5-labeled Pt-Dd localized in the late endosomal compartment of HeLa or CHO cells after incubation at 37°C for 1 h (Fig. 7 E), as expected for the HAdV3 pathway [40], [77]–[79]. The usefulness of baculovirus-mediated labeling of specific organelles for tracking adenovirus particles or adenoviral components within living cells was therefore validated using our in-house model of HAdV3 Pt-Dd.

Electron microscopy (EM) of cell-internalized HAdV5wt and HAdV5F35 particles in the presence of FX

To further explore the cellular localization of internalized vector particles in the presence of FX, CHO-K1 cells were incubated with HAdV5wt or HAdV5F35 vector (MOI 10,000) alone or complexed with FX (8 µg/ml). Cells were harvested at 2 h pi at 37°C, and processed for EM. As expected for CAR-negative cells transduced in the absence of FX, rare HAdV5wt virions were observed within the cells, in vesicles (Fig. 8 A, i) or free in the cytoplasm (Fig. 8 A, ii). Occasionally, HAdV5wt virions were seen attached to the invaginated plasma membrane forming clathrin-coated vesicles: in such cases, the average distance of the capsid to the plasma membrane was found to be 25±4 nm (m ± SEM), a value consistent with the length of serotype 5 fiber (Fig. 8 A, iii and iv). This suggested that in the absence of CAR and FX, HAdV5wt bound directly to components of the CHO-K1 plasma membrane acting as alternative receptors. In the presence of FX however, HAdV5wt found in vesicles seemed to be associated with electron lucent material (Fig. 8 B, i). Very rare HAdV5wt particles were found within the cells at 2 h pi, likely due to their rapid transit to the nucleus and traverse of the nuclear pore (Fig. 8 B, ii).

thumbnail
Download:
Figure 8. Electron microscopy of CHO-K1 cells incubated with HAdV5wt at 10,000 vp/cell, (A) in the absence (w/o), or (B) presence of FX (8 µg/ml) for 2 h at 37°C.

(A), (i) and (ii): General views of cell sections showing (i) intravesicular and (ii) cytoplasmic vector particles. In (iii) and (iv), a vector particle (Vir) is seen within a clathrin-coated vesicle (CCV); (iv), enlargement of the CCV shown in (iii), with measurements of the space between the vector particle and the inner leaflet of the vesicular membrane. N, nucleus; NPC, nuclear pore complexes viewed in a tangential section. (B), (i): vector particle within an endocytic vesicle in the vicinity of a nuclear pore; (ii), viral core seen in the process of traverse of the nuclear pore.

https://doi.org/10.1371/journal.pone.0018205.g008

The pattern was different for CHO-K1 cells incubated with FX-HAdV5F35 complex for 2 h at 37°C. No particle with the regular shape of adenovirions was observed in any of the cellular compartments, but each cell section showed large vesicles containing abundant, electron dense material (Fig. 9 a). This pattern was consistent with the results of confocal microscopy showing the accumulation of FX-HAdV5F35 complexes in lysosomes (refer to Fig. 7). Interestingly at the cell surface, HAdV5F35 particles were frequently seen connected to the plasma membrane via a bridge consisting of filamentous material (Fig. 9 b–d). The length of these bridges varied from 80 to 140 nm, with an average at 105 nm, a value compatible with the thickness of the fibrilllous glycocalyx coat (77 to 201 nm; [80]). By contrast, in control CHO-CD46 cells incubated with HAdV5F35 vector in the absence of FX, cell-bound particles were seen at a distance of 13±2 nm from the plasma membrane outer leaflet (Fig. 9 e), a value compatible with the short-shafted serotype 35 fiber bound to its CD46 receptor. Enlargements of cell-bound HAdV5F35 particles showed fuzzy material decorating the viral capsid (Fig. 9 d), conferring the whole complex a diameter of 107±6 nm, instead of 80–85 nm for free virions (Fig. 9: compare the sharp contour of the control HAdV5F35 virion in panel e to the blurred contour of FX-HAdV5F35 complex in panel d). We hypothesize that the filaments emanating from the cell which bridged the vector to the cell surface represented HSPG, components of the cell glycocalyx [80], whereas the fuzzy material which coated the capsid corresponded to FX molecules bound to hexon.

thumbnail
Download:
Figure 9. Electron microscopy of CHO-K1 cells (a–d) incubated with HAdV5F35 at 10,000 vp/cell in the presence of FX (8 µg/ml), and harvested after 2 h at 37°C.

(a), Representative CHO-K1 cell section showing a cytoplasmic vesicle containing abundant electron dense material. (b–d), Cell surface-bound HAdV5F35 particles. (e), CHO-CD46 cells incubated with HAdV5F35 in the absence of FX (w/o FX). Note the difference in size and sharpness of the viral contour between HAdV5F35 particles seen in (e) and in (b–d).

https://doi.org/10.1371/journal.pone.0018205.g009

Cellular uptake and retention of FX with or without adenoviral particles

Our observation that FX enhanced the vector-cell binding for both HAdV5wt and HAdV5F35, but failed to augment the FX-HAdV5F35-mediated cell transduction, raised the question of the fate of FX after the cell attachment of the FX-vector complex: was FX coendocytosed with HAdV5wt or HAdV5F35, or did it remain outside of the cell? To address this issue, Alexa-555-labeled FX was preincubated with Alexa-488-labeled vector particles, and the complex added to CHO-K1 cells. As control, Alexa-555-labeled FX was added to CHO-K1 cells alone, without preincubation with the vector. Both types of samples were followed by live cell imaging. We found that FX alone could bind to CHO-K1 cells and was rapidly endocytosed: intracellular FX was detected as early as 15–20 min post incubation (Fig. 10 A). No detectable cellular uptake of FX was observed in HSPG-deficient CHO-2241 cells (not shown). In CHO-K1 cells incubated with the double labeled FX-HAdV5wt complex, both fluorescent signals were observed within the cell at 15–20 min pi, and most signals colocalized in cytoplasmic dots and patches (Fig. 10 B). At later times pi (45–60 min), HAdV5wt particles were found to localize at the nuclear periphery or inside the nucleus, and less colocalization with FX was visible (Fig. 10 C). In CHO-K1 cells incubated with double labeled FX-HAdV5F35 complex, FX and virions remained colocalized within the cytoplasm until late times pi (3 h pi; Fig. 10 D). This confirmed the rapid intracellular transit of HAdV5wt, in contrast to the slow trafficking and vesicular retention of HAdV5F35.

thumbnail
Download:
Figure 10. Confocal microscopy of live cells (CHO-K1) incubated with (A) Alexa-555-labeled FX alone (8 µg/ml), or (B, C) in complex with Alexa-488-labeled HAdV5wt, or (D) in complex with Alexa-488-labeled HAdV5F35, both vectors used at 10,000 vp/cell.

Images were taken at 10-min intervals, until 3 h post incubation (pi). (i), phase contrast image; (ii) orange channel; (iii) green channel.

https://doi.org/10.1371/journal.pone.0018205.g010

We next investigated whether the vesicular retention or sequestration of HAdV5F35 could be explained by a higher stability of FX-HAdV5F35 complex in the acidic environment of the late endosomal compartment, compared to the higher pH of early endosomes, the endocytic compartment of HAdV5wt. This was determined indirectly, using SPR analysis of the apparent affinity between FX and serotype 5 hexon, the capsomeres which were in common between HAdV5F35 and HAdV5wt and the targets of FX. FX was covalently immobilized onto the biosensor chip, and hexon protein diluted in the same 0.05 M phosphate buffer but with the different Na2HPO4∶NaH2PO4 ratios required to obtain the desired pH values. The sensorgrams obtained showed that the profile of binding of serotype 5 hexon to FX was significantly higher at pH 5.7, compared to neutral pH, with an intermediate interaction observed at pH 6.3 (Fig. 11). This suggested that the FX-HAdV5F35 complex dissociated at slower rate in the acidic environment of late endosomal vesicles, compared to that of FX-HAdV5 complex in early endosomes. This vesicular sequestration would account for the lower transduction efficiency of (i) the FX-HAdV5F35 complex, compared to FX-HAdV5wt complex (refer to Fig. 5, panels a and b), and (ii) of the FX-HAdV5F35 complex, compared to the HAdV5F35 vector alone (refer to Fig. 5, panels b).

thumbnail
Download:
Figure 11. SPR analysis of the pH-dependence of FX∶hexon protein interaction.

FX was immobilized on the sensorchip, and a hexon protein solution in 150 mM NaCl, 0.05 M sodium phosphate buffer of various pH values was injected into the flowcell.

https://doi.org/10.1371/journal.pone.0018205.g011

Discussion

It was recently shown that HAdV5 interaction with human blood coagulation FX, which results in the formation of FX-HAdV5 complexes, is the major parameter responsible for the massive liver uptake of HAdV5 vector particles administered systemically. FX binds to the hexon capsomeres via its Gla domain, and subsequently interacts with cell surface-exposed HSPG molecules which are present in abundance at the surface of liver Kupffer cells [25]–[34]. This prompted several laboratories to engineer HAdV5-based vectors with hexon modifications designed to abolish the FX binding and reduce their hepatotropism (reviewed in [24]). However, the species B member HAdV35 [36], the serotype 35 fiber-pseudotyped vector HAdV5F35 [37], and the HAdV5/35 chimeric vector carrying serotype 35 fiber knobs [38] all showed a decreased hepatotropism, compared to HAdV5. Likewise HAdV5F2/BAdV4, another fiber-pseudotyped vector which carried human-bovine chimeric fibers, was able to bind to FX in vitro, but ineffective to promote liver transduction in vivo [39]. The fact that both HAdV5F35 and HAdV5F2/BAdV4 vectors carried the same hexon capsomere serotype and varied only in their fiber subtype incited us to explore the role of the fiber in the cell entry pathway and transduction mediated by HAdV5-based vectors in the presence of FX.

Our results confirmed that FX bound to HAdV5 hexon protein via its Gla-domain and enhanced the binding of serotype 5 hexon protein and HAdV5wt virus particles to surface-immobilized HS. We also found that FX promoted the interaction of HS with HAdV5FTTAT and HAdV5PbEGD mutants in vitro, significantly enhanced the cell transduction by HAdV5wt, and was able to rescue the lower infectivity of HAdV5FTTAT and HAdV5PbEGD mutants. Since FX contains a RGD tripeptide motif at position 227–229, it was conceivable that in the case of HAdV5PbEGD mutant, FX might compensate for the integrin binding defect of penton base EGD mutant. However, this hypothesis could be excluded for two reasons: (i) activated FX (FXa) which had lost the activation peptide (amino acid sequence 183–234) including the RGD motif, showed the same effect on HAdV5PbEGD infectivity as RGD-containing FX (data not shown); (ii) the activity of FX required the presence of HSPG at the cell surface, whereas RGD-dependent integrins seemed to be dispensable.

Intriguingly, however, we found that, although FX promoted the binding of fiber-pseudotyped vector HAdV5F35 to HS in vitro and to cellular HSPG in vivo, it failed to enhance, but instead decreased, the HAdV5F35-mediated transduction of CAR- and CD46-negative, but HSPG-positive CHO cells. It was recently hypothesized that the absolute levels of CAR, CD46, and HSPG on the surface of target cells would define the importance of FX in modulating cell binding and transduction mediated by HAdV5, HAdV35, and serotype 5/35 chimeric viruses: thus, in the presence of FX, the high affinity of serotype 35 fiber for CD46 would overcome the serotype 5 hexon∶FX interaction, resulting in reduced liver transduction by the chimeric vector HAdV5F35 in vivo, compared to HAdV5 [37]. However, this did not explain the limitation by FX of the transduction of CHO-CD46 cells in vitro by chimeric vectors carrying serotype 35 fibers, as previously reported [37], and observed in the present study (refer to Fig. 5), or the lower transduction of CD46 transgenic hepatocytes by a chimeric HAdV5/35 vector in vivo [38]. In the latter study, CD46-transgenic mice injected with a HAdV5/35-based chimeric vector carrying serotype 35 fiber knobs showed a two orders of magnitude lower liver transduction and 20-fold lower adenoviral genome content, compared to HAdV5-based vector [38].

Our analysis of the cell entry and trafficking pathway of HAdV5F35 vector in complex with FX provided some clues to reconcile these apparent contradictions, and to understand the possible mechanisms underlying the FX effect. We showed that FX augmented by 10-fold the attachment and cellular uptake of HAdV5F35, and confirmed that the negative effect of FX on HAdV5F35-mediated cell transduction did not result from a binding defect at the cell attachment step, but was due to intracellular mechanisms, as previously hypothesized [37]. According to our data, (i) the primum movens was the fiber 35-mediated addressing of HAdV5F35 particles (bound or unbound to FX) to the late endosomal/lysosomal compartment; (ii) FX-bound HAdV5F35 particles remained sequestered in this compartment, due to the higher stability of the FX-HAdV5F35 complexes in an acidic environment, which in turn (iii) delayed the trafficking of HAdV5F35 particles to the nucleus. (iv) An additional mechanism involved the exocytic pathway: following the cellular uptake of FX-HAdV5F35 complexes, significant amounts of exosome-associated HAdV5F35 were released in the extracellular milieu, a phenomenon which was not observed in the absence of FX. This was not observed with HAdV5wt either, with or without FX. Our results therefore addressed the puzzling question why, in contrast to HAdV5 vectors, fiber-chimeric vectors such as HAdV5F35 do not efficiently transduce liver cells after intravenous injection, although they contain the same HAdV5 hexons, which mediate binding to heparan sulfate on liver cells via blood FX. Our data suggested that the retention of HAdV5F35 particles in late endosomal compartments, triggered by HAdV35 fibers, was further enhanced by the hexon∶FX∶heparan sulfate interaction. This mechanism led to an abortion of HAdV5F35 transduction in the presence of FX, and most likely explained why HAdV5F35 vectors do not transduce liver cells after intravenous injection in mice.

The intracellular trafficking pathway of subspecies B HAdVs has been well studied [41], [58]. It has been shown that, despite high levels of binding to cells and similar internalization kinetics, fiber-pseudotyped or full serotype species B HAdVs remain in late endosomes or lysosomes for relatively long periods of time after infection, and take significantly longer than species C HAdV to reach the nucleus [41], [58]. This supposedly favored the recycling of the vectors to the cell surface and reduce their transduction efficiency, in contrast to HAdV5. Our experimental data on exosomal release of serotype 35 fiber-pseudotyped vector HAdV5F35 infection in the presence of FX supported the latter hypothesis. In conclusion, FX would be benefical to the infection of CAR-lacking cells by species C HAdVs, e.g. HAdV5, which transit via the early endosomal pathway, but detrimental to species B HAdVs, e.g. HAdV35, which follow the late endosomal pathway.

In the light of the acid stability of the FX-HAdV5F35 complex that we observed, it remained to explain the relative efficient transduction of CHO-CD46 cells by HAdV5F35 in the presence of FX (refer to Fig. 5). We assume that in the absence of CD46, such as in CHO-K1 cells, only the alternative receptors HSPG via the intermediate ligand FX would mediate the cell binding and entry of HAdV5F35, and all or nearly all vector particles would be complexed with FX, and retarded or trapped within the late vesicular compartment. In the presence of CD46 receptors however, e.g. in CHO-CD46 cells, FX became dispensable, and a significant number of free, FX-unbound HAdV5F35 particles would be endocytosed via the CD46 pathway. These free particles would normally escape the late endosomal vesicles and reach the nucleus, unlike FX-complexed HAdV5F35 particles.

Previous analyses of the intracellular fate of chimeric adenoviruses have shown that the fiber protein is the major determinant of the cell trafficking of incoming virions [57], [58], [81]. Thus, the targeting of HAdV5 pseudotyped with fibers of serotype 7 (a serotype belonging to species B HAdV) to the lysosomal pathway is under the control of the fiber serotype [57]. The present study provided another example of dominant effect of species B fiber, serotype 35 fiber, which occurred in the absence of CD46 and any other cognate fiber receptor at the plasma membrane. The endocytosis and retention of FX-HAdV5F35 complex in the late endosomal compartment, characteristic of species B HAdVs [41], [58], implied that the nature of the adenoviral fiber was dominant over the high affinity serotype 5 hexon∶FX interaction as a determinant of the choice of the endocytic compartment and intracellular trafficking pathway of HAdV particles. This confirmed previous reports on the intracellular functions associated with the fibers carried by incoming adenovirions [57], [58], [70], [81], [82]. The molecular mechanism and factors involved in the cellular traffic determinism of adenoviral fiber remains an open question, but should be taken into consideration in the future design of target tissue-redirected adenoviral vectors.

Materials and Methods

Cell lines

E1A-E1B-trans-complementing HEK-293 cell line (abbreviated 293; CRL 1573) was obtained from the American Type Culture Collection (Manassas, Va). HEK-293 cells were cultured as monolayers in DMEM supplemented with 10% fetal calf serum (FCS, Sigma), penicillin (200 U/ml), and streptomycin (200 µg/ml; Gibco-Invitrogen) at 37°C and 5% CO2. The 293-derived, fiber-trans-complementing cell line, abbreviated 293-Fiber, was obtained from Transgene SA (Strasbourg, France). 293-Fiber cells were grown in the same medium as 293 cells, supplemented with hygromycin at 350 µg/ml [70], [83]. Chinese hamster ovary cells CHO-K1, and proteoglycan-deficient CHO-2241 cells (pgsB-618, ATCC code CRL-2241) were obtained from the European Collection of Cultured Cells via the Institut de Biologie Structurale, Grenoble, France [79]. CAR-expressing CHO cells (CHO-CAR) were obtained from Dr. J. Bergelson [4], and CD46-expressing CHO cells (CHO-CD46) from Dr. D. Gerlier [84]. CHO-K1, CHO-2241, CHO-CAR and CHO-CD46 cells were cultured as monolayers in Alpha-MEM supplemented with 10% FCS, penicillin and streptomycin as above (Gibco-Invitrogen). All cells were incubated at 37°C under 5% CO2 .

HAdV5-based vectors and nomenclature

Replication-deficient HAdV5 vectors (E1A–E1B, and E3 deleted) expressing GFP were propagated in trans-complementing cell line 293. Their genetic construction and phenotypes have been described in detail in previous studies [85]–[93]. Since all the vectors used in the present study contained the same reporter gene coding for the green fluorescent protein (EGFP) cloned downstream to the hCMV promoter, their acronyms did not specify this reporter gene, in contrast to our previous studies. For reason of simplification, their acronyms only referred to the capsid component serotype and to the protein mutated, penton base (Pb) or fiber (F).

(i) HAdV5 vector with wild-type (wt) capsid.

Control HAdV5 vector with nonmodified capsid was abbreviated HAdV5wt.

(ii) Penton base mutant.

Mutant HAdV5PbEGD carried a RGD-to-EGD substitution at position 340 in the penton base coding sequence.

(iii) Fiber shaft substitution mutant.

In the HAdV5FTTAT vector, the KKTK motif at position 91–94 in the fiber shaft domain was modified into 91-TATT-94 using conventional PCR-based mutagenesis [88], [91].

(iv) Chimeric fiber vector HAdV5F35.

HAdV5F35 carried the HAdV serotype 35 fiber knob and shaft domains fused to the HAdV5 fiber tail [68], [85].

Adenovirus purification and titration

HAdV5-based vectors were purified by CsCl gradient ultracentrifugation using conventional methods [85], [94]. The infectious titer of the HAdV5 vector stocks was determined by the plaque assay method in HEK-293 or in double trans-complementing cell line 293-Fiber [70] for HAdV5 fiber mutants, and expressed as PFU per ml [91], [92]. The titer in physical particles (viral particles; vp) was determined by absorbance measurement at 260 nm (A260) of 1-ml samples of SDS-denatured virions (0.1% SDS for 1 min at 56°C) in a 1-cm-path-length cuvette, using the respective formula: A260 of 1.0 = 1.1×1012 vp/ml for HAdV5 (genomic DNA = 36 kbp). HAdV5 particle titers ranged from 5×1011 to 1×1012 vp/ml, with infectious titers between 2×1010 and 5×1010 PFU/ml [95].

Fluorescent labeling of adenovirus particles and FX protein

Alexa Fluor® 488 dye (tetrafluorophenyl ester; Molecular Probes; Invitrogen), and Alexa Fluor® 555 dye (succinimidyl ester; Molecular Probes; Invitrogen), were abbreviated Alexa-488 and Alexa-555, respectively. Random labeling of HAdV5wt or HAdV5F35 vector particles with Alexa-488 was carried out as follows. Aliquots of 1×1012 vector particles in suspension in 0.05 M HEPES buffer pH 7.2 (900 µl, final volume) were incubated with chemically reactive Alexa-488 used at a 20-fold excess over the 18,000 amino groups present at the surface of the adenoviral capsid, for 2 h at room temperature (RT) and in argon atmosphere. The reaction was stopped by adding 100 µl 1 M lysine solution in 0.05 M HEPES buffer pH 7.2, corresponding to a 5-fold excess of lysine over the Alexa-488 reagent. After 1 h incubation at RT, the labeled-vector particles were separated from unreacted dye by gel filtration on a PD10 column. For labeling of FX protein with Alexa-555, FX protein (5 mg/ml) was reacted with 1 mM Alexa Fluor® 555 dye in 0.05 M HEPES buffer pH 7.2, for 1 h at RT, and excess of unreacted dye eliminated by dialysis against PBS.

Live cell imaging and time-lapse microscopy

Samples of CHO-K1 or CHO 2241 cell monolayers (5×105 cells/well) were seeded directly onto poly L-lysine-coated glass dishes (Mattek Corp., USA), and maintained in the appropriate medium at 37°C for 24 h. Cells were infected with 35 µl of recombinant baculovirus suspension expressing fluorescent markers of cellular organelles or compartments (CellLight™ Lysosomes-RFP and CellLight™ Endosomes-RFP *BacMam 2.0*) per cm2 of monolayer in serum-free medium for 4 h at RT, according to the supplier instructions (Invitrogen). Suspension was then withdrawn and replaced by culture medium supplemented with 10% FCS. Cell samples were further incubated overnight at 37°C under 5% CO2 atmosphere, then processed for infection with fluorescent-labeled vector particles, as follows. The following day, the cells were washed with cold PBS (4°C), and overlaid with 1 ml fresh and cold (4°C) medium. Alexa-488-labeled vector particles (10,000 vp/cell, in a volume of 100 µl) were added to the medium, and incubated on ice for 1 h. The cells were then washed 3 times with PBS, followed by fresh and cold (4°C) medium. Cell samples were kept on ice until they were transferred to 37°C in the incubation chamber of the confocal microscope. Observations were performed from 10 min to 3 h pi, using an inverted confocal laser scanning microscope (LSM 510 Meta; Carl Zeiss, IAB), equipped with a 63× oil immersion objective (Plan-Apochromat 63×/1.4) and a humidified CO2- and temperature-controlled incubation chamber. The Alexa-488 dye was excited by the Argon laser and the emission was collected with a BP 500–550 nm filter. Orange channel used 543 nm HeNe laser excitation and LP560 emission filter. The images were mainly collected in the focal plane crossing the cell nucleus with a resolution of 512×512 pixels (Zoom 1) and 4× line average. The collection time was 3 s per channel. The pinhole of the fluorescence channels was set to one Airy unit corresponding to the optical section of less than 1 µm and the signal intensity was adjusted with a PMT gain to completely fill the detector dynamic range. The two channels were acquired in a sequential mode to avoid spectral cross-talk, and the acquisition of transmitted light image was concomitant with the green channel.

Flow cytometry

Aliquots of cells (2×105 per well) were seeded in fully supplemented appropriate medium into 24-well plates. 24 h later, the cells were washed three times with PBS, and 500 µl of appropriate medium containing 1% penicillin/streptomycin and 10% glutamine but no FCS was added. For transduction assays, different vector preparations were added to the medium at various MOI, with or without incubation with FX at different concentrations. After 2 h, the cells were extensively washed with PBS prewarmed at 37°C, then 1 ml of fresh fully supplemented medium was added and cells further incubated at 37°C for an additional 22 h. Cells were resuspended in PBS and analyzed by flow cytometry, using a FACSCanto™ II cytometer (Becton Dickinson Biosciences). 20,000 events were acquired for each sample and the results were analyzed using the DIVA 6 software (Becton Dickinson).

Surface plasmon resonance (SPR) assays

The source of naturally hypersulfated heparin (HS), sodium salt, was the porcine intestinal mucosa (Sigma). HS calibrated to 9 kDa was biotinylated and immobilized on a CM4 BIAcore sensorchip (GE Healthcare, Saclay, France), using a BIAcore3000 (GE Healthcare), as previously described [48], [49]. Two flowcells were prepared by sequential injections of EDC/NHS, streptavidin, and ethanolamine. One of these flowcells served as negative control, while biotinylated heparin was injected on the other one, to get an immobilization level of 80–90 response units (RU). All SPR experiments were performed using HBS buffer (10 mM HEPES, 150 mM NaCl, pH 7.4) supplemented by 3 mM CaCl2, at a flow rate of 5 µl/min. Interaction assays involved injections of different amounts of protein or virus over the heparin-coated and negative control surfaces, followed by a 3-min dissociation time with buffer. At the end of each cycle, the heparin surface was regenerated by injections of 2 M NaCl (2 min). Sensorgrams shown corresponded to on-line subtraction of the negative control to the heparin surface signal.

Preparation of plasma membrane-shedded microvesicles (MVs) and MVB-released exosomes (EXOs)

(i) Source of MVs and EXOs.

Confluent CHO-K1 cells were transduced with HAdV5wt or HAdV5F35 at MOI 5,000, with or without FX, and harvested at 2 h and 24 h pi. The cell culture medium was harvested and floating cells were pelleted by centrifugation at 2,000× g for 10 min. The supernatant was further clarified from cell debris by centrifugation for 2 min at 13,000× g and 4°C. This final supernatant (S0) was the source of plasma membrane-derived MVs and EXOs, prepared as described in [96].

(ii) Isolation of MV.

Fraction S0 was centrifuged for 2 h at 30,000× g and 4°C, and pellet P1 was saved: it mainly contained MVs.

(iii) Isolation of EXOs.

Supernatant S1 was further centrifuged at 100,000× g and 4°C for 2 h, giving supernatant S2, which was discarded, and pellet P2, which contained EXOs. Pellets were resupended in PBS and subjected to DNA extraction, using QIAamp DNA Blood Mini kit (Quiagen).

Quantification of AdV vector genomes by real-time PCR and real-time RT-PCR

HAdV5 vectors which were possibly carried over with MVs were detected and quantitated by real-time PCR, using HAdV5 or HAdV35 specific primers and probe selected from the fiber gene. Extraction of DNA was carried out using the QIAamp DNA Blood Mini Kit (Quiagen) and real time PCR reactions were carried out using the LightCycler DNA Master SYBR Green I kit (Roche) and the LightCycler instrument (Roche). For the serotype 5 fiber gene, the primers used were: sense 5′-GCTACAGTTTCAGTTTTGGCTG-3′ and antisense 5′-GTTGTGGCCAGACCAGTCCC-3′ ; for the serotype 35 fiber gene, the primers used were : sense 5′- TGGCTTCACACAAAGCCCAGACG-3′ and antisense 5′- ACACGTAGCCATTAACAAGCCCTCC-3′. As internal control, ß-actin gene was amplified using the following primers, sense 5′-GCTGTGTTCTTGCACTCCTTG-3′ and antisense 5′- CGCACGATTTCCCTCTCAGC-3′.

Proteins

FX, activated FX (FXa) which lacked the RGD motif contained in the activation peptide [97], and the truncated form FXGL (Gla domainless) were all purchased from CRYOPREP (Montpellier, France). Proteolytically inactive human FX, blocked with Dansyl-EGR (FX-DEGR), was also purchased from CRYOPREP. HAdV5wt hexon, penton (penton base + fiber) and fiber proteins were isolated from lysates of HAdV5wt-infected 293 cells [85]. HAdV5wt penton base and penton base RGD-340-EGD mutant, were recombinant proteins isolated from recombinant baculovirus-infected cells [98], [99]. Viral proteins were purified according to a conventional protocol adapted to fast protein liquid chromatography [100]–[103]. Protein samples were analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and western blotting, as previously described [85].

Adenovirus type 3 penton dodecahedron (Pt-Dd) purification, labeling and intracellular trafficking

HAdV3 Pt-Dd was produced in recombinant baculovirus-infected insect cells coexpressing HAdV3 penton base and fibre proteins, as previoulsy described [40], [77]–[79]. HAdV3 Pt-Dd was purified by sucrose gradient density, and dialysed against HEPES-NaCl buffer (20 mM HEPES, pH 7.4, 150 mM NaCl). Fluorescent-labeled Pt-Dd was obtained by incubation of a Pt-Dd protein solution at 1 mg/ml with Cy5-monoNHS-Ester at 1 mM (GE Healthcare, PA15101) for 2 h at room temperature, followed by extensive dialysis against PBS to remove unbound dye. Cy5-labeled Pt-Dd (10 µg/ml) was incubated at 37°C for 10 min to 2 h with CHO-CD46 cells transduced one day before with recombinant baculovirus suspension expressing the Lamp1 fluorescent marker of the late endosome/lysosome compartment (CellLight™ Lysosomes-RFP *BacMam 2.0*; Invitrogen), as described above. After removal of Cy5-labeled Pt-Dd and rinsing the cell monolayer with prewarmed medium, live imaging was performed using the LSM 510 Meta inverted confocal laser scanning microscope (Carl Zeiss, IAB) as above, with the RFP and Cy5 filters.

Electron microscopy (EM)

Specimens were processed for EM and observed as previously described [104], [105]. In brief, cells were harvested at 2 h pi, pelleted, fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer, pH 7.5, post-fixed with osmium tetroxide (2% in H20) and treated with 0.5% tannic acid solution in H20. The specimens were dehydrated and embedded in Epon (Epon-812; Fulham, Latham, NY). Ultrathin sections were stained with 2.6% alkaline lead citrate and 0.5% uranyl acetate in 50% ethanol, and post-stained with 0.5% uranyl acetate solution in H2O. Grids were examined under a Jeol JEM-1400 electron microscope, equipped with an ORIUS™ digitalized camera (Gatan France, 78113-Grandchamp). For statistical EM analyses, a minimum of 50 grid squares containing 5 to 10 cell sections each were examined for counting virions in different cell compartments.

Statistics

Results were expressed as mean ± SEM. of n observations. Sets of data were compared with an analysis of variance (ANOVA) or a Student's t test. Differences were considered statistically significant when P<0.05. Symbols used in figures were (*) for P<0.05, (**) for P<0.01, (***) for P<0.001, and ns for no significant difference, respectively. All statistical tests were performed using GraphPad Prism version 4.0 for Windows (Graphpad Software).

Acknowledgments

We are grateful to Elisabeth Errazuriz-Cerda, Jonathan Girard, Chantal Thevenon and Christophe Vanbelle (Centre Commun d'Imagerie de Laennec, Faculty of Medicine, Lyon), for their valuable assistance in our electron microscopy and flow cytometry analyses, to Daphna Fenel and Guy Schoehn for the quality control of adenovirions and hexon capsomeres by transmission EM. We are also grateful to Nicole Thielens and Isabelle Bally (IBS platform of the Partnership for Structural Biology and Institut de Biologie Structurale in Grenoble) for assistance and access to the Biacore facility, and to Sylvie Farget and Cathy Berthet for their efficient secretarial aid. We thank INSERM (Institut National de la Santé et de la Recherche Médicale) for supporting this project, which received a negative evaluation from the Scientific Committee of the French AERES (Agence d'Evaluation de la Recherche et de l'Enseignement Supérieur).

Author Contributions

Conceived and designed the experiments: SSH PB PF. Performed the experiments: SC GG AG SSH PF. Analyzed the data: SC GG AG PB PF SSH. Contributed reagents/materials/analysis tools: PH LL. Wrote the paper: PB PF SSH.

References

  1. 1. Mitraki A, Papanikolopoulou K, Van Raaij MJ (2006) Natural triple beta-stranded fibrous folds. Adv Protein Chem 73: 97–124.
  2. 2. Russell WC (2000) Update on adenovirus and its vectors. J Gen Virol 81: 2573–2604.
  3. 3. Russell WC (2009) Adenoviruses: update on structure and function. J Gen Virol 90: 1–20.
  4. 4. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, et al. (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320–1323.
  5. 5. Bergelson JM, Krithivas A, Celi L, Droguett G, Horwitz MS, et al. (1998) The murine CAR homolog is a receptor for Coxsackie B viruses and adenoviruses. J Virol 72: 415–419.
  6. 6. Kirby I, Davison E, Beavil AJ, Soh CP, Wickham TJ, et al. (2000) Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein. J Virol 74: 2804–2813.
  7. 7. Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, et al. (1998) The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J Virol 72: 7909–7915.
  8. 8. Roelvink PW, Mi Lee G, Einfeld DA, Kovesdi I, Wickham TJ (1999) Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae. Science 286: 1568–1571.
  9. 9. Santis G, Legrand V, Hong SS, Davison E, Kirby I, et al. (1999) Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR. J Gen Virol 80: 1519–1527.
  10. 10. Tomko RP, Johansson CB, Totrov M, Abagyan R, Frisen J, et al. (2000) Expression of the adenovirus receptor and its interaction with the fiber knob. Exp Cell Res 255: 47–55.
  11. 11. Tomko RP, Xu R, Philipson L (1997) HCAR and mCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B Coxsackieviruses. Proc Natl Acad Sci USA 94: 3352–3356.
  12. 12. Nemerow GR (2000) Cell receptors involved in adenovirus entry. Virology 274: 1–4.
  13. 13. Wickham TJ, Carrion ME, Kovesdi I (1995) Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs. Gene Ther 2: 750–756.
  14. 14. Wickham TJ, Filardo EJ, Cheresh DA, Nemerow GR (1994) Integrin alphavbeta5 selectively promotes adenovirus mediated cell membrane permeabilization. J Cell Biol 127: 257–264.
  15. 15. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR (1993) Integrins alphavbeta3 and alphavbeta5 promote adenovirus internalization but not virus attachment. Cell 73: 309–319.
  16. 16. Meier O, Greber UF (2003) Adenovirus endocytosis. J Gene Med 5: 451–462.
  17. 17. Wang K, Huang S, Kapoor-Munshi A, Nemerow GR (1998) Adenovirus internalization and infection require dynamin. J Virol 72: 3455–3458.
  18. 18. Wiethoff CM, Wodrich H, Gerace L, Nemerow GR (2005) Adenovirus protein VI mediates membrane disruption following capsid disassembly. J Virol 79: 1992–2000.
  19. 19. Wodrich H, Henaff D, Jammart B, Segura-Morales C, Seelmeir S, et al. (2010) A capsid-encoded PPxY-motif facilitates adenovirus entry. PLoS Pathog 6: e1000808.
  20. 20. Kelkar SA, Pfister KK, Crystal RG, Leopold PL (2004) Cytoplasmic dynein mediates adenovirus binding to microtubules. J Virol 78: 10122–10132.
  21. 21. Leopold PL, Kreitzer G, Miyazawa N, Rempel S, Pfister KK, et al. (2000) Dynein- and microtubule-mediated translocation of adenovirus serotype 5 occurs after endosomal lysis. Hum Gene Ther 11: 151–165.
  22. 22. Greber UF, Suomalainen M, Stidwill RP, Boucke K, Ebersold MW, et al. (1997) The role of the nuclear pore complex in adenovirus DNA entry. EMBO J 16: 5998–6007.
  23. 23. Trotman LC, Mosberger N, Fornerod M, Stidwill RP, Greber UF (2001) Import of adenovirus DNA involves the nuclear pore complex receptor CAN/Nup214 and histone H1. Nat Cell Biol 3: 1092–1100.
  24. 24. Coughlan L, Alba R, Parker AL, Bradshaw AC, McNeish IA, et al. (2010) Tropism-modification strategies for targeted gene delivery using adenoviral vectors. Viruses 2: 2290–2355.
  25. 25. Alba R, Bradshaw AC, Parker AL, Bhella D, Waddington SN, et al. (2009) Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer. Blood 114: 965–971.
  26. 26. Kalyuzhniy O, Di Paolo NC, Silvestry M, Hofherr SE, Barry MA, et al. (2008) Adenovirus serotype 5 hexon is critical for virus infection of hepatocytes in vivo. Proc Natl Acad Sci USA 105: 5483–5488.
  27. 27. Parker AL, McVey JH, Doctor JH, Lopez-Franco O, Waddington SN, et al. (2007) Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D. J Virol 81: 3627–3631.
  28. 28. Parker AL, Nicklin SA, Baker AH (2008) Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications. Curr Opin Mol Ther 439–448.
  29. 29. Parker AL, Waddington SN, Buckley SM, Custers J, Havenga MJ, et al. (2009) Effect of neutralizing sera on factor x-mediated adenovirus serotype 5 gene transfer. J Virol 83:
  30. 30. Parker AL, Waddington SN, Nicol CG, Shayakhmetov DM, Buckley SM, et al. (2006) Multiple vitamin K-dependent coagulation zymogens promote adenovirus-mediated gene delivery to hepatocytes. Blood 108: 2554–2561.
  31. 31. Shayakhmetov DM, Gaggar A, Ni S, Li ZY, Lieber A (2005) Adenovirus binding to blood factors results in liver cell infection and hepatotoxicity. J Virol 79: 7478–7491.
  32. 32. Vigant F, Descamps D, Jullienne B, Esselin S, Connault E, et al. (2008) Substitution of hexon hypervariable region 5 of adenovirus serotype 5 abrogates blood factor binding and limits gene transfer to liver. Mol Ther 16: 1474–1480.
  33. 33. Waddington SN, McVey JH, Bhella D, Parker AL, Barker K, et al. (2008) Adenovirus serotype 5 hexon mediates liver gene transfer. Cell 132: 397–409.
  34. 34. Waddington SN, Parker AL, Havenga MJ, Nicklin SA, Buckley SM, et al. (2007) Targeting of adenovirus serotype 5 (Ad5) and 5/47 pseudotyped vectors in vivo: fundamental involvement of coagulation factors and redundancy of CAR binding by Ad5. J Virol 81: 9568–9571.
  35. 35. Bradshaw AC, Parker AL, Duffy MR, Coughlan L, van Rooijen N, et al. (2010) Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X. PLoS Pathog 6: e1001142.
  36. 36. Sakurai F (2008) Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35. Biol Pharm Bull 31: 1819–1825.
  37. 37. Greig JA, Buckley SM, Waddington SN, Parker AL, Bhella D, et al. (2009) Influence of coagulation factor X on in vitro and in vivo gene delivery by adenovirus (Ad) 5, Ad35, and chimeric Ad5/Ad35 vectors. Mol Ther 17: 1683–1691.
  38. 38. Ganesh S, Gonzalez-Edick M, Gibbons D, Waugh J, Vanroey M, et al. (2009) Evaluation of biodistribution of a fiber chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice. Hum Gene Ther 20: 1201–1213.
  39. 39. Rogée S, Grellier E, Bernard C, Jouy N, Loyens A, et al. (2010) Influence of chimeric human-bovine fibers on adenoviral uptake by liver cells and the antiviral immune response. Gene Ther 17: 880–891.
  40. 40. Wang H, Li ZY, Liu Y, Persson J, Beyer I, et al. (2010) Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14. Nat Med. 2010 Dec 12 [Epub ahead of print].
  41. 41. Gaggar A, Shayakhmetov DM, Lieber A (2003) CD46 is a cellular receptor for group B adenoviruses. Nature Med 8: 746–755.
  42. 42. Tuve S, Wang H, Jacobs JD, Yumul RC, Smith DF, et al. (2008) Role of cellular heparan sulfate proteoglycans in infection of human adenovirus serotype 3 and 35. PLoS Pathogens 4: e1000189.
  43. 43. Tuve S, Wang H, Ware C, Liu Y, Gaggar A, et al. (2006) A new group B adenovirus receptor is expressed at high levels on human stem and tumor cells. J Virol 80: 12109–12120.
  44. 44. Wu E, Trauger SA, Pache L, Mullen TM, Von Seggern DJ, et al. (2004) Membrane cofactor protein is a receptor for adenoviruses associated with epidemic keratoconjunctivitis. . J Virol 78: 3897–3905.
  45. 45. Dechecchi MC, Melotti P, Bonizzato A, Santacatterina M, Chilosi M, et al. (2001) Heparan sulfate glycosaminoglycans are receptors sufficient to mediate the initial binding of adenovirus types 2 and 5. J Virol 75: 8772–8780.
  46. 46. Dechecchi MC, Tamanini A, Bonizzato A, Cabrini G (2000) Heparan sulfate glycosaminoglycans are involved in adenovirus type 5- and 2-host cell interactions. Virology 268: 382–390.
  47. 47. Gaden F, Franqueville L, Hong SS, Legrand V, Figarella C, et al. (2002) Mechanism of restriction of normal and cystic fibrosis transmembrane conductance regulator-deficient human tracheal gland cells to adenovirus (Ad) infection and Ad-mediated gene transfer. Am J Respir Cell Mol Biol 27: 628–640.
  48. 48. Vivès RR, Lortat-Jacob H, Chroboczek J, Fender P (2004) Heparan sulfate proteoglycan mediates the selective attachment and internalization of serotype 3 human adenovirus dodecahedron. Virology 321: 332–340.
  49. 49. Vives RR, Sadir R, Imberty A, Rencurosi A, Lortat-Jacob H (2002) A kinetics and modeling study of RANTES(9–68) binding to heparin reveals a mechanism of cooperative oligomerization. Biochemistry 41: 14779–14789.
  50. 50. Bayo-Puxan N, Cascallo M, Gros A, Huch M, Fillat C, et al. (2006) Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting. J Gen Virol 87: 2487–2495.
  51. 51. Kritz AB, Nicol CG, Dishart KL, Nelson R, Holbeck S, et al. (2007) Adenovirus 5 fibers mutated at the putative HSPG-binding site show restricted retargeting with targeting peptides in the HI loop. Mol Ther 15: 741–749.
  52. 52. Rezaie AR (2000) Identification of basic residues in the heparin-binding exosite of factor Xa critical for heparin and factor Va binding. J Biol Chem 275: 3320–3327.
  53. 53. Murakami S, Sakurai F, Kawabata K, Okada N, Fujita T, et al. (2007) Interaction of penton base Arg-Gly-Asp motifs with integrins is crucial for adenovirus serotype 35 vector transduction in human hematopoietic cells. Gene Ther 14: 1525–1533.
  54. 54. Nemerow GR, Stewart PL (1999) Role of alpha(v) integrins in adenovirus cell entry and gene delivery. Microbiol Mol Biol Rev 63: 725–734.
  55. 55. Huang S, Kamata T, Takada Y, Ruggeri ZM, Nemerow GR (1996) Adenovirus interaction with distinct integrins mediates separate events in cell entry and gene delivery to hematopoietic cells. J Virol 70: 4502–4508.
  56. 56. Kawakami Y, Li H, Lam JT, Krasnykh V, Curiel DT, et al. (2003) Substitution of the adenovirus serotype 5 knob with a serotype 3 knob enhances multiple steps in virus replication. Cancer Res 63: 1262–1269.
  57. 57. Miyazawa N, Crystal RG, Leopold PL (2001) Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein. J Virol 75: 1387–1400.
  58. 58. Miyazawa N, Leopold PL, Hackett NR, Ferris B, Worgall S, et al. (1999) Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J Virol 73: 6056–6065.
  59. 59. Myhre S, Henning P, Granio O, Tylo AS, Nygren PA, et al. (2007) Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector. Gene Ther 14: 376–381.
  60. 60. Nanda A, Lynch DM, Goudsmit J, Lemckert AA, Ewald BA, et al. (2005) Immunogenicity of recombinant fiber-chimeric adenovirus serotype 35 vector-based vaccines in mice and rhesus monkeys. J Virol 14161–14168. 2005 Nov;79(22):14161-8 79.
  61. 61. Chiu CY, Wu E, Brown SL, Von Seggern DJ, Nemerow GR, et al. (2001) Structural analysis of a fiber-pseudotyped adenovirus with ocular tropism suggests differential modes of cell receptor interactions. J Virol 75: 5375–5380.
  62. 62. Di Paolo NC, Kalyuzhniy O, Shayakhmetov DM (2007) Fiber shaft-chimeric adenovirus vectors lacking the KKTK motif efficiently infect liver cells in vivo. J Virol 81: 12249–12259.
  63. 63. Schoggins JW, Gall JG, Falck-Pedersen E (2003) Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J Virol 77: 1039–1048.
  64. 64. Stevenson SC, Rollence M, Marshall-Neff J, McClelland A (1997) Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein. J Virol 71: 4782–4790.
  65. 65. Toyoda E, Doi R, Kami K, Mori T, Ito D, et al. (2008) Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells. Int J Oncol 33: 1141–1147.
  66. 66. Von Seggern DJ, Huang S, Fleck SK, Stevenson SC, Nemerow GR (2000) Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J Virol 74: 354–362.
  67. 67. Zabner J, Chillon M, Grunst T, Moninger TO, Davidson BL, et al. (1999) A chimeric type 2 adenovirus vector with a type 17 fiber enhances gene transfer to human airway epithelia. J Virol 73: 8689–8695.
  68. 68. Granio O, Ashbourne Excoffon KJ, Henning P, Melin P, Norez C, et al. (2010) Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia. Hum Gene Ther 21: 251–269.
  69. 69. Darr S, Madisch I, Hofmayer S, Rehren F, Heim A (2009) Phylogeny and primary structure analysis of fiber shafts of all human adenovirus types for rational design of adenoviral gene-therapy vectors. J Gen Virol 90: 2849–2854.
  70. 70. Gaden F, Franqueville L, Magnusson MK, Hong SS, Merten MD, et al. (2004) Gene transduction and cell entry pathway of fiber-modified Adenovirus type 5 vectors carrying novel endocytic peptide ligands selected on human tracheal glandular cells. J Virol 78: 7227–7247.
  71. 71. Colin M, Mailly L, Rogée S, D'Halluin J-C (2005) Efficient species C HAdV infectivity in plasmocytic cell lines using a clathrin-independent lipid raft/caveola endocytic route. Mol Ther 11: 224–236.
  72. 72. Cocucci E, Racchetti G, Meldolesi J (2009) Shedding microvesicles : artefacts no more. Trends Cell Biol 19: 43–51.
  73. 73. Greber UF, Willetts M, Webster P, Helenius A (1993) Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75: 477–486.
  74. 74. Falcón-Pérez JM, Nazarian R, Sabatti C, Dell'Angelica EC (2005) Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J Cell Sci 118: 5243–5255.
  75. 75. Shaner NC, Campbell RE, Steinbach PA, Giepmans BNG, Palmer AE, et al. (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. . Nat Biotechnol 12: 1567–1572.
  76. 76. Mairhofer M, Steiner M, Salzer U, Prohaska R (2009) Stomatin-like protein-1 interacts with stomatin and is targeted to late endosomes. J Biol Chem 284: 29218–29229.
  77. 77. Fender P, Schoehn G, Foucaud-Gamen J, Gout E, Garcel A, et al. (2003) Adenovirus dodecahedron allows large multimeric protein transduction in human cells. J Virol 77: 4960–4964.
  78. 78. Fender P, Ruigrok RW, Gout E, Buffet S, Chroboczek J (1997) Adenovirus dodecahedron, a new vector for human gene transfer. Nat Biotechnol 15: 52–56.
  79. 79. Fender P, Schoehn G, Perron-Sierra F, Tucker GC, Lortat-Jacob H (2008) Adenovirus dodecahedron cell attachment and entry are mediated by heparan sulfate and integrins and vary along the cell cycle. Virology 371: 155–164.
  80. 80. van den Berg BM, Vink H, Spaan JA (2003) The endothelial glycocalyx protects against myocardial edema. Circ Res 92: 592–594.
  81. 81. Shayakhmetov DM, Li ZY, Ternovoi V, Gaggar A, Gharwan H, et al. (2003) The interaction between the fiber knob domain and the cellular attachment receptor determines the intracellular trafficking route of adenoviruses. J Virol 77: 3712–3723.
  82. 82. Shayakhmetov DM, Lieber A (2000) Dependence of adenovirus infectivity on length of the fiber shaft domain. J Virol 74: 10274–10286.
  83. 83. Uil TG, de Vrij J, Vellinga J, Rabelink MJ, Cramer SJ, et al. (2009) A lentiviral vector-based adenovirus fiber-pseudotyping approach for expedited functional assessment of candidate retargeted fibers. J Gene Med 11: 990–1004.
  84. 84. Devaux P, Loveland B, Christiansen D, Milland J, D. G (1996) Interactions between the ectodomains of haemagglutinin and CD46 as a primary step in measles virus entry. J Gen Virol 1477–1481.
  85. 85. Franqueville L, Henning P, Magnusson MK, Vigne E, Schoehn G, et al. (2008) Protein crystals in adenovirus type 5-infected cells: requirements for intranuclear crystallogenesis, structural and functional analysis. PLoS One 3: e2894.
  86. 86. Henning P, Andersson KME, Frykholm K, Ali A, Magnusson MK, et al. (2005) Tumor cell targeted gene delivery by adenovirus 5 vectors carrying knobless fibers with antibody-binding domains. Gene Ther 12: 211–224.
  87. 87. Henning P, Lundgren E, Carlsson M, Frykholm K, Johannisson J, et al. (2006) Adenovirus type 5 fiber knob domain has a critical role in fiber protein synthesis and encapsidation. J Gen Virol 87: 3151–3160.
  88. 88. Henning P, Magnusson MK, Gunneriusson E, Hong SS, Boulanger P, et al. (2002) Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. Hum Gene Ther 13: 1427–1439.
  89. 89. Hong SS, Magnusson MK, Henning P, Lindholm L, Boulanger PA (2003) Adenovirus stripping: a versatile method to generate adenovirus vectors with new cell target specificity. Mol Ther 7: 692–699.
  90. 90. Magnusson MK, Henning P, Myhre S, Wikman M, Uil TG, et al. (2007) Adenovirus 5 vector genetically re-targeted by an Affibody molecule with specificity for tumor antigen HER2/neu. Cancer Gene Ther 14: 1–12.
  91. 91. Magnusson MK, Hong SS, Boulanger P, Lindholm L (2001) Genetic retargeting of adenovirus: novel strategy employing “deknobbing” of the fiber. J Virol 75: 7280–7289.
  92. 92. Magnusson MK, Hong SS, Henning P, Boulanger P, Lindholm L (2002) Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J Gene Med 4: 356–370.
  93. 93. Waszak P, Franqueville L, Franco-Motoya M-L, Rosa-Calatrava M, Boucherat O, et al. (2007) Toxicity of fiber- and penton base-modified adenovirus type 5 vectors on lung development in newborn rats. Mol Ther 15: 2008–2016.
  94. 94. Defer C, Belin M-T, Caillet-Boudin M-L, Boulanger P (1990) Human adenovirus-host cell interactions: comparative study with members of subgroups B and C. J Virol 64: 3661–3673.
  95. 95. Granio O, Porcherot M, Corjon S, Kitidee K, Henning P, et al. (2009) Improved adenovirus type 5 vector-mediated transduction of resistant cells by piggybacking on coxsackie B-adenovirus receptor-pseudotyped baculovirus. J Virol 83: 6048–6066.
  96. 96. Théry C, Clayton A, Amigorena S, Raposo G (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protocols Cell Biol Suppl 30: 3.22.21–23.22.29.
  97. 97. Venkateswarlu D, Perera L, Darden T, Pedersen LG (2002) Structure and Dynamics of Zymogen Human Blood Coagulation Factor X. Biophys J 82: 1190–1206.
  98. 98. Karayan L, Gay B, Gerfaux J, Boulanger P (1994) Oligomerization of recombinant penton base of adenovirus type 2 and its assembly with fiber in baculovirus-infected cells. Virology 202: 782–795.
  99. 99. Karayan L, Hong SS, Gay B, Tournier J, d'Angeac AD, et al. (1997) Structural and functional determinants in adenovirus type 2 penton base recombinant protein. J Virol 71: 8678–8689.
  100. 100. Boulanger P, Puvion F (1973) Large-scale preparation of soluble adenovirus hexon, penton and fiber antigens in highly purified form. Eur J Biochem 39: 37–42.
  101. 101. Molinier-Frenkel V, Gahery-Segard H, Mehtali M, Le Boulaire C, Ribault S, et al. (2000) Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytes. J Virol 74: 7678–7682.
  102. 102. Molinier-Frenkel V, Lengagne R, Gaden F, Hong SS, Choppin J, et al. (2002) Adenovirus hexon protein is a potent adjuvant for activation of a cellular immune response. J Virol 76: 127–135.
  103. 103. Molinier-Frenkel V, Prévost-Blondel A, Hong SS, Lengagne R, Boudaly S, et al. (2003) The maturation of murine dendritic cells induced by human Adenovirus is mediated by the fiber knob domain. J Biol Chem 278: 37175–37182.
  104. 104. DaFonseca S, Blommaert A, Coric P, Hong SS, Bouaziz S, et al. (2007) The 3-O-(3′,3′-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells. Antiviral Ther 12: 1185–1203.
  105. 105. DaFonseca S, Coric P, Gay B, Hong SS, Bouaziz S, et al. (2008) The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3′,3′-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain. Virol J 5: 162.